Guardian Pharmacy Services, Inc. GRDN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 90.26% | 142.21% | 40.72% | 75.19% | 108.04% |
| Total Depreciation and Amortization | 1.61% | 5.81% | 13.46% | 11.41% | 16.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.65% | -12.73% | -31.99% | -8.59% | -95.56% |
| Change in Net Operating Assets | 135.95% | -575.56% | -851.66% | 309.27% | 125.54% |
| Cash from Operations | 53.96% | 50.61% | -65.46% | 54.90% | 1,401.71% |
| Capital Expenditure | 22.68% | -7.25% | 13.54% | 6.09% | -1.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -76.01% | -- | -- | 78.00% | -80.47% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.82% | 161.71% | -- | -90.55% | -7.98% |
| Cash from Investing | -21.60% | 66.89% | 14.34% | 28.89% | -26.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 34.45% | 9.18% | 1.33% | 97.60% | 97.98% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,027.16% | 124.12% | 39.96% | 110.53% | 100.13% |
| Cash from Financing | -70.84% | 61.92% | 23.56% | 98.43% | -103.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.92% | 417.10% | -107.77% | 189.47% | -50.48% |